BRD0209 is a potent, selective and dual inhibitor of GSK3alpha/beta inhibitor (GSK3alpha IC50 = 19 nM, GSK3beta IC50 = 5 nM). BRD0209 is also a reversible ATP-competitive inhibitor with fast-off kinetics (Ki = 4.2 nM, respectively). BRD0209 is a tricyclic pyrazolotetrahydroquinolinone compound. BRD0209 has the potential for the research of mood disorder diseases[1].
Molecular Weight:
347.45
Purity:
99.63
CAS Number:
[1597439-87-6]
Formula:
C22H25N3O
Target:
GSK-3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
